Whole Slide Imaging Market Size, Share, and Industry Analysis, By Component (Hardware and Software), By Application (Histopathology, Cytopathology, Immunohistochemistry, Hematopathology, and Others), By End-user (Hospitals & Pathology Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others), and Regional Forecast, 2026-2034

The whole slide imaging market size was valued at USD 1.23 billion in 2025 and is expected to reach a market valuation of USD 1.38 billion in 2026. Furthermore, the market is projected to reach a market valuation of USD 3.36 billion by 2034, exhibiting a CAGR of 11.8% during the forecast period.

The market is growing significantly as digital pathology adoption replaces conventional microscope-based workflows in diagnostics. In such a scenario, whole slide imaging enables digitization of glass slides, making storage, retrieval, review, and case sharing much easier.

Whole Slide Imaging Market Driver

Growing Demand for Telepathology and Remote Consultation to Drive the Market Growth

Over the past few years, there has been an increased demand for telepathology and remote consultation. In such a scenario, whole slide imaging allows pathologists to review cases remotely and share digital slides across locations, addressing pathologist shortages in underserved areas. This is anticipated to drive the market expansion in the forthcoming years.

• For instance, according to the study published by the National Center for Biotechnology Information (NCBI) in March 2026, the percentage of hospitals using telepathology software rose at an average annual rate of 7.60%, climbing from 29.5% (137 out of 464) in 2018 to 42.6% (80 out of 188) in 2023.

Download Free sample to learn more about this report.

According to data from the American Hospital Association, there were approximately 6,100 hospitals in the U.S. as of early 2026.

Whole Slide Imaging Market Restraint

High Capital Investment and Implementation Cost to Hamper the Market Growth

Whole slide imaging systems require significant upfront spending on scanners, software, IT infrastructure, storage, and workflow integration. This may limit adoption, especially among small- and mid-sized laboratories, hindering market expansion in the coming years. Moreover, workflow challenges and validation complexity are also expected to limit the utilization of whole slide imaging technology, hindering market growth.

Whole Slide Imaging Market Opportunity

Increasing Use in Pharmaceutical and Research Applications to Offer Lucrative Growth Opportunity

In recent years, pharmaceutical & biotechnology companies have increasingly used digital pathology in drug discovery, preclinical studies, biomarker research, and translational medicine. This is expected to boost demand for whole slide imaging beyond routine hospital diagnostics. Moreover, a large number of pharmaceutical companies in developed countries are contributing to this demand.

• For instance, according to the data from the Cross River Therapy in March 2026, there are more than 5,000 pharmaceutical companies in the U.S.

Segmentation

Key Insights

The report covers the following key insights:

• Advancements in Whole Slide Imaging
• Key Industry Developments - (Partnerships, Mergers, and Acquisitions, etc.)

Analysis by Component

By component, the market is segmented into hardware and software.

The hardware segment is expected to hold the major share of the global market during the forecast period. The growth is attributed to the increasing installation of high-throughput scanners in hospitals and labs, as well as to continuous upgrades to advanced imaging systems.

Analysis by Application

By application, the market is segmented into histopathology, cytopathology, immunohistochemistry, hematopathology, and others.

The histopathology segment is expected to hold the major share of the global market during the forecast period, as it accounts for a significant volume of diagnostic testing, particularly in cancer diagnosis. Moreover, whole slide imaging is most widely used for digitizing tissue sections in routine pathology workflows.

Analysis by End-user

Based on end-user, the market is divided into hospitals & pathology laboratories, pharmaceutical & biotechnology companies, academic & research institutes, and others.

The hospitals & pathology laboratories segment is expected to hold the largest share of the global market during the forecast period. These settings are primary users of WSI systems as they handle the majority of diagnostic workloads and pathology testing. Moreover, a large number of pathology laboratories in developed countries is favoring demand for WSI systems, which is anticipated to drive the segment’s growth.

• For instance, as of March 2026, according to data from Laboratory of Florida LLC., there are around 8,680 hospital-based labs and 5,414 independent labs in the U.S.

Regional Analysis

Request for Customization   to gain extensive market insights.

Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America accounted for a 44.8% share of the global whole slide imaging market in 2025. The growth is supported by advanced healthcare infrastructure, early adoption of digital pathology, and strong research funding in the region. As a result, regulatory authorities have approved several WSI systems in the region, thereby increasing penetration.

• For instance, in June 2024, F. Hoffmann-La Roche Ltd received FDA 510(k) clearance for its VENTANA DP 200 Digital Pathology Dx system, including a slide scanner, workflow software, and display, to aid pathologists in primary clinical diagnosis using digital slide images.

Asia Pacific is expected to grow at the highest CAGR during the forecast period. The growth is fueled by expanding healthcare infrastructure, rising cancer burden, improved pathology capacity, and the growing adoption of digital tools in large hospitals and diagnostic networks across key countries such as China, India, and Japan.

Key Players Covered

The global whole slide imaging market is moderately consolidated, as key players compete on scanner performance, image quality, throughput capacity, software interoperability, and regulatory approvals to enhance their market position.

The report includes the profiles of the following key players

• Koninklijke Philips N.V. (Netherlands)
• Leica Biosystems Nussloch GmbH (Germany)
• Hamamatsu Photonics K.K (Japan)
• 3DHISTECH Ltd. (Hungary)
• Hoffmann-La Roche Ltd (Switzerland)
• Grundium Oy (Finland)
• Motic (Hong Kong)
• PreciPoint GmbH (Germany)
• OptraScan (India)
• EVIDENT (Germany)

Key Industry Developments

• November 2025: Hologic, Inc. introduced digital pathology capabilities through an expanded CE marking for its Genius Digital Diagnostics System. This upgrade enables advanced whole-slide imaging and AI-assisted analysis, enhancing lab efficiency across Europe.
• March 2023: Hamamatsu Photonics and Siemens Healthineers AG announced a multi-year distribution agreement for NanoZoomer whole slide scanners to support digital pathology expansion in the Americas and Europe.